Geographic and Racial Variability in Kidney, Cardiovascular, and Safety Outcomes With Canagliflozin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial
Diabetes Obes Metab 2024 Jun 19;[EPub Ahead of Print], K Cardoza, A Kang, B Smyth, TW Yi, C Pollock, R Agarwal, G Bakris, DM Charytan, D de Zeeuw, DC Wheeler, H Zhang, CP Cannon, V Perkovic, C Arnott, A Levin, KW MahaffeyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.